Last reviewed · How we verify
bupivacaine and methylprednisolone
bupivacaine and methylprednisolone is a Small molecule drug developed by Bursa Yuksek Ihtisas Training and Research Hospital. It is currently FDA-approved. Also known as: suprascapular nerve block.
At a glance
| Generic name | bupivacaine and methylprednisolone |
|---|---|
| Also known as | suprascapular nerve block |
| Sponsor | Bursa Yuksek Ihtisas Training and Research Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Arthrosemid vs. Steroid for the Management Knee Osteoarthritis (PHASE4)
- Efficacy of Nerve Blocks for Episodic Migraine (PHASE2)
- Ultrasound-Guided Thoracic Paravertebral Block With Steroid and Local Anesthetic for Acute Herpes Zoster: Effects on Pain Control and Prevention of Postherpetic Neuralgia (PHASE3)
- Corticosteroid Injection Versus Nerve Block (NA)
- COntralateral CorticoSTeroid Injection in Total Knee Arthroplasty (PHASE1, PHASE2)
- iPACK Block vs. Periarticular Infiltration for TKA Pain Control (NA)
- Stem Cells vs. Steroids for Discogenic Back Pain (NA)
- Efficacy of Combining Caudal Epidural Steroid With Ganglion Impar Block in Chronic Coccydynia
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- bupivacaine and methylprednisolone CI brief — competitive landscape report
- bupivacaine and methylprednisolone updates RSS · CI watch RSS
- Bursa Yuksek Ihtisas Training and Research Hospital portfolio CI
Frequently asked questions about bupivacaine and methylprednisolone
What is bupivacaine and methylprednisolone?
bupivacaine and methylprednisolone is a Small molecule drug developed by Bursa Yuksek Ihtisas Training and Research Hospital.
Who makes bupivacaine and methylprednisolone?
bupivacaine and methylprednisolone is developed and marketed by Bursa Yuksek Ihtisas Training and Research Hospital (see full Bursa Yuksek Ihtisas Training and Research Hospital pipeline at /company/bursa-yuksek-ihtisas-training-and-research-hospital).
Is bupivacaine and methylprednisolone also known as anything else?
bupivacaine and methylprednisolone is also known as suprascapular nerve block.
What development phase is bupivacaine and methylprednisolone in?
bupivacaine and methylprednisolone is FDA-approved (marketed).
Related
- Manufacturer: Bursa Yuksek Ihtisas Training and Research Hospital — full pipeline
- Also known as: suprascapular nerve block
- Compare: bupivacaine and methylprednisolone vs similar drugs
- Pricing: bupivacaine and methylprednisolone cost, discount & access